Organon & Co. (OGN) — insider trading
Health Care · NYSE
Organon & Co. (OGN) has 23 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 2 open-market sales among the most recent 23 (latest 2026-08-11).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | Arjona Ferreira Juan Camilo | Officer (Head of R&D & CMO) | Option exercise / conversion (derivative) | 11,519 | — | $0 | Form 4 |
| 2026-08-11 | Arjona Ferreira Juan Camilo | Officer (Head of R&D & CMO) | Shares withheld for taxes / exercise cost | 4,134 | $13.62 | $56.3K | Form 4 |
| 2026-08-11 | Arjona Ferreira Juan Camilo | Officer (Head of R&D & CMO) | Option exercise / conversion | 11,519 | — | $0 | Form 4 |
| 2026-08-05 | Drinane Juliana Papa | Officer (Head of Mfg & Supply) | Open-market sale | 14,761 | $13.57 | $200.3K | Form 4 |
| 2026-06-12 | ESSNER ROBERT | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Ezekowitz Alan | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Gayle Helene D | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | LAZARUS ROCHELLE B | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Leone Deborah R | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Ozuah Philip | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Patton Cynthia M | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Sequeira Ramona | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-06-12 | Sharp Shalini | Director | Grant / award / vesting (derivative) | 17,857 | $13.44 | $240.0K | Form 4 |
| 2026-05-06 | Holzbaur Lynette | Officer (SVP and Corporate Controller) | Open-market purchase | 26,448 | $13.35 | $353.1K | Form 4 |
| 2026-05-06 | Holzbaur Lynette | Officer (SVP and Corporate Controller) | Open-market sale | 26,448 | $13.35 | $353.1K | Form 4/A |
| 2026-05-06 | Holzbaur Lynette | Officer (SVP and Corporate Controller) | Other acquisition or disposition | 46 | — | $0 | Form 4/A |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Option exercise / conversion (derivative) | 10,073 | — | $0 | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Option exercise / conversion (derivative) | 6,378 | — | $0 | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Grant / award / vesting (derivative) | 125,208 | — | $0 | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Shares withheld for taxes / exercise cost | 3,451 | $5.70 | $19.7K | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Option exercise / conversion | 10,073 | — | $0 | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Shares withheld for taxes / exercise cost | 2,185 | $5.70 | $12.5K | Form 4 |
| 2026-03-31 | Drinane Juliana Papa | Officer (Interim Head of Mfg & Supply) | Option exercise / conversion | 6,378 | — | $0 | Form 4 |
Ask the chat about OGN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Organon & Co. (OGN).
Last updated 2026-08-11 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.